In a paper in the journal “Science”, researchers from the Vienna BioCenter combine cutting-edge technologies to decipher regulatory functions of important cancer genes. Key to this success is an innovative method called “SLAMseq”, which allows...
Read More »Lexogen and Bluebee Partner to Bring the SLAMseq Metabolic RNA Sequencing Data Analysis Pipeline to the Users
Bluebee, a company driving genomic data-driven medicine, and Lexogen a company enabling the analysis of the complete transcriptome, announce the successful integration of the SLAMdunk pipeline on Bluebee‘s private cloud-based platform, making it available to analyze data generated by every user ...
Read More »Lexogen commercializes thiol-linked alkylation method for the metabolic sequencing of RNA
Today Lexogen, the transcriptomics and next-generation sequencing company, launched the SLAMseq product family for high throughput metabolic sequencing of RNA. The kits are based on a new technology developed at the Institute of Molecular Biotechnology (IMBA) at the Vienna BioCenter in ...
Read More »